Numerical data for Fig 3A, 3C, 3D, 3F, 3I, 3J and 3L. by Amy E. Schade (15368259)

Subjects:

Combined EZH2 and HDAC inhibitors kill CRPC cells and trigger regression of CRPCs in vivo. by Amy E. Schade (15368259)

Subjects:

Numerical data for S3A and S3D Fig. by Amy E. Schade (15368259)

Subjects:

List of 2,258 genes identified as genes who lost H3K27me3 in response to EZH2i (PRC2 target genes). by Amy E. Schade (15368259)

Subjects:

Numerical data for S4 Fig. by Amy E. Schade (15368259)

Subjects:

EZH2 and HDAC inhibitors cooperatively derepress a subset of PRC2 targets in CRPC. by Amy E. Schade (15368259)

Subjects:

Numerical data for Fig 2A, 2B, 2C, 2D and 2G. by Amy E. Schade (15368259)

Subjects:

FIGURE 3 from Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance by Debarshi Banerjee (17620899)

Supplementary Figure S2 from Circadian Clock Gene <i>Bmal1</i> Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma by Qingming Tang (397327)

A coarse-grained sensitivity analysis of the effect of drug-induced resistance on treatment outcome. by Erin Angelini (13149930)

Figure 7 from Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression by Denis Ohlstrom (15030192)

Image_1_Acidification of intracellular pH in MM tumor cells overcomes resistance to hypoxia-mediated apoptosis in vitro and in vivo.jpg by Gilberto Gastelum (4662967)

Image_2_Acidification of intracellular pH in MM tumor cells overcomes resistance to hypoxia-mediated apoptosis in vitro and in vivo.jpg by Gilberto Gastelum (4662967)

Supplementary Figure 1 from Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors by Sandra Ortiz-Cuaran (320342)

Supplementary Figure 3 from Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors by Sandra Ortiz-Cuaran (320342)

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

Subjects:

Data Supplement from The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF by Ian R. Watson (11911913)

Supplementary Figures from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer by Yajing Liu (728964)

Development of Anticancer Ferric Complex Based on Human Serum Albumin Nanoparticles That Generate Oxygen in Cells to Overcome Hypoxia-Induced Resistance in Metal Chemotherapy by Ronghao Fang (16377903)

“…The <b>HSA–Fe1–O</b>_<b>2</b> NP (<b>HSA–Fe1–O</b>_<b>2</b><b>NP</b>) delivery system effectively overcame hypoxia-induced resistance in metal chemotherapy, alleviated the hypoxic condition of tumor tissues, and showed excellent tumor suppression by generating excess ROS and promoting the apoptosis of SK-N-MC tumor cells. …”

Figure 3 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors by Christopher T. Chen (19665314)